SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-035926
Filing Date
2022-12-19
Accepted
2022-12-19 21:06:32
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7525
  Complete submission text file 0001493152-22-035926.txt   8956
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 13357 RUSSET LEAF LN. SAN DIEGO CA 92129
Business Address
Litchev Boyan Vesselinov (Reporting) CIK: 0001902726 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 221472707